Uptravi 60 Tabs 1600 mcg
60 Tabs — 1600 mcg
Uptravi (selexipag) is a medication used to treat pulmonary arterial hypertension, a rare form of high blood pressure in the arteries of the lungs. It works by relaxing and widening blood vessels, allowing blood to flow more easily and reducing pressure.
- Active ingredient: Selexipag
Uptravi is a revolutionary new prescription medication designed to help improve the lives of people living with pulmonary arterial hypertension. Using a unique combination of two active ingredients, Uptravi helps reduce the symptoms of PAH by relaxing the blood vessels in the lungs and allowing more blood to flow through them. The result is improved exercise capacity, reduced shortness of breath, and improved quality of life. Uptravi is easy to take, with most patients taking one tablet daily, and has been proven to be safe and effective in clinical trials. Uptravi is a breakthrough for PAH patients, and with it, they can enjoy a life of greater activity, freedom and vitality.